RNAi
September 26, 2024
Confronting the World’s Leading Killer with a New Therapeutic Approach
For Xicang Guo and Jiaming Zhang, one particular condition remains stubbornly beyond their control – hypertension, also known as high blood pressure.
Read More ›
September 12, 2024
RNAi Therapeutics, from Possibility to Patients
The story of an innovative approach to silencing disease that’s improving lives and changing expectations for medicine.
Read More ›
December 14, 2023
R&D Day 2023 Recap: Following the Science to Deliver on the Promise of RNAi Therapeutics
During our 2023 R&D Day, our leadership discussed several exciting innovations and provided a look ahead at the rapid growth and evoltuion of our pipeline.
Read More ›
August 9, 2023
RNAi Therapeutics on the European Pharmaceutical Review Podcast
Paul Nioi, PhD, VP of Discovery and Translational Research discussed RNAi therapeutics on the The European Medical Review Podcast.
Read More ›
March 16, 2023
Alnylam's Paul Nioi, PhD on The Genetics Podcast: Using Genetics in Drug Target Discovery
Paul Nioi, PhD, VP of Discovery and Translational Research and Head of Alnylam Human Genetics recently spoke with Dr. Patrick Short on The Genetics Podcast.
Read More ›
March 10, 2023
Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics
Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics
Read More ›
February 4, 2022
Alnylam Receives Prestigious Massachusetts Economic Impact Award
We are pleased and honored to have been named a Gold Team Massachusetts Economic Impact Award winner for 2022 by MassEcon.
Read More ›
May 1, 2020
John Maraganore on the "I Am BIO" Podcast: Destroying COVID's Genome
Our CEO John Maraganore recently spoke with Biotechnology Innovation Organization (BIO) CEO and Chairman Jim Greenwood on the "I Am BIO" podcast.
Read More ›
October 1, 2019
The Importance of Ensuring Quality in a New Class of Medicines
In Product Quality, we have a truly big picture view of the medicines we’re making to ensure they are compliant with good manufacturing practices and...
Read More ›
October 1, 2019
Building for Our Future
Why would a company without a commercially approved medicine decide to build a significant manufacturing facility? Why not continue to rely on contract...
Read More ›
